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Non-invasive kinetic modelling of PET
tracers with radiometabolites using a
constrained simultaneous estimation method:
evaluation with 11C-SB201745
Hasan Sari1* , Kjell Erlandsson1, Lisbeth Marner2,3, Ian Law3, Henrik B.W. Larsson3,
Kris Thielemans1, Sébastien Ourselin4, Simon Arridge4, David Atkinson5 and Brian F. Hutton1,6
Abstract
Background: Kinetic analysis of dynamic PET data requires an accurate knowledge of available PET tracer
concentration within blood plasma over time, known as the arterial input function (AIF). The gold standard method
used to measure the AIF requires serial arterial blood sampling over the course of the PET scan, which is an invasive
procedure and makes this method less practical in clinical settings. Traditional image-derived methods are limited to
specific tracers and are not accurate if metabolites are present in the plasma.
Results: In this work, we utilise an image-derived whole blood curve measurement to reduce the computational
complexity of the simultaneous estimation method (SIME), which is capable of estimating the AIF directly from tissue
time activity curves (TACs). This method was applied to data obtained from a serotonin receptor study (11C-SB207145)
and estimated parameter results are compared to results obtained using the original SIME and gold standard AIFs
derived from arterial samples. Reproducibility of the method was assessed using test-retest data. It was shown that
the incorporation of image-derived information increased the accuracy of total volume of distribution (VT) estimates,
averaged across all regions, by 40% and non-displaceable binding potential (BPND) estimates by 16% compared to the
original SIME. Particular improvements were observed in K1 parameter estimates. BPND estimates, based on the
proposed method and the gold standard arterial sample-derived AIF, were not significantly different (P = 0.7).
Conclusions: The results of this work indicate that the proposed method with prior AIF information obtained from a
partial volume corrected image-derived whole blood curve, and modelled parent fraction, has the potential to be
used as an alternative non-invasive method to perform kinetic analysis of tracers with metabolite products.
Keywords: Positron emission tomography, PET/MR, Kinetic modelling, Arterial input function
Background
Kinetic analysis methods are often used to extract quanti-
tative measurements from positron emission tomography
(PET) scans, such as cerebral blood flow, metabolism
and receptor distribution. The majority of these methods
require a precise knowledge of the arterial input func-
tion (AIF) to obtain the concentration of the available PET
tracer in the blood plasma. However, measurement of the
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AIF can be a challenging task in dynamic PET studies,
particularly when radioactive metabolites are present in
the blood. In such cases, the fraction of the metabolite-
free parent compound needs to be determined before
performing kinetic analysis.
The gold standard method to measure the AIF is arte-
rial blood sampling which involves serial blood sampling
from a radial artery during the course of the scan. These
samples are then analysed to determine the concentra-
tion of the PET tracer in blood plasma over time. In the
presence of radiometabolites, additional arterial samples
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
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are often required to determine the metabolite and par-
ent compound fractions. Although it is regarded as the
most accurate method for the measurement of the AIF,
arterial sampling is often avoided in practice due to its
invasiveness.
Image-derived input function (IDIF) estimation is often
regarded as a more practical alternative to arterial sam-
pling, where the AIF is derived from reconstructed PET
images [1–3]. IDIF methods suffer from the limited res-
olution of PET scanners which can cause partial volume
(PV) effects. Some researchers propose the use of anatom-
ical information from MR or CT images to correct for
PV effects and improve the accuracy of derived IDIFs
[4, 5]. However, IDIF methods alone are not able to
separate the concentration of parent compound when
radioactive metabolites are present in the blood. In such
cases, several blood samples are still required to perform
metabolite correction [1, 6].
An alternative AIF estimation method used in brain
studies is the simultaneous estimation method (SIME)
which is based on estimating the AIF by fitting multi-
ple tissue time activity curves (TACs) derived from dif-
ferent brain regions [7, 8]. In this approach, the AIF
is defined as a parametric model where its parameters
are simultaneously estimated with kinetic rate constants
for brain tissues. This method was initially proposed
for use in 18F-FDG studies but was later shown to be
applicable to other tracers [6]. Since the AIF is esti-
mated purely computationally in SIME, this method can
be particularly useful to derive the metabolite-free AIF
non-invasively from the PET data. However, simultane-
ous estimation of AIF and kinetic rate constants from
multiple regions involves estimation of a large number
of parameters, resulting in bias and poor precision in
the estimates [7]. Due to this problem, SIME is often
complemented with several blood samples obtained at
late time points to scale the estimated AIF. Furthermore,
AIFs estimated using SIME tend to have accurate area
under the curve but not necessarily the exact AIF shape,
especially during the period following injection. Simi-
lar to conventional compartmental modelling, SIME can
be more robust in deriving the macroparameters, such
as volume of distribution (VT) and binding potentials
(BP), rather than individual kinetic parameters [9]. This
is due to macroparameters being a function of kinetic
parameters which are correlated. Hence, errors on kinetic
parameter estimates often cancel out in the calculation of
macroparameters.
We have previously shownwith simulated 18F-FDG data
that the performance of the SIME method can be sig-
nificantly improved if some prior information about the
early part of the AIF can be included from another source,
such as an image-based measurement or an MRI-derived
AIF [10]. In other work, prior AIF bolus information was
utilised in 18F-FDG studies and was shown to work well
when complemented with late blood samples [11].
Another source of uncertainty in SIME is the presence
of cerebral blood volume (CBV) in TACs. Although this
volume is usually small in TACs extracted from brain
regions, the contribution of the tracer concentration in
the CBV to the total TAC might not be negligible and
needs to be accounted for in the kinetic modelling. In
the original SIME, the total tissue output of each region
is modelled by summing the products of estimated par-
ent AIF with the tissue and blood concentrations. This
approach is not ideal since the CBV component is linked
to whole blood concentration rather than the parent AIF
and these concentrations can have substantial differences
over the course of the scan.
In this article, we propose a constrained SIME method
which utilises information from an image-derived whole
blood curve [5] to reduce the complexity of the SIME.
Our aim is to aid the SIME optimisation by using this
image-based measurement to define the AIF peak and
to differentiate whole blood activity from parent tracer
activity in the plasma. Our ultimate goal is to develop a
fully non-invasive method to perform kinetic analysis of
PET tracers with metabolites. The method is evaluated in
a study using 11C-SC207145 [12] which is a radioligand
used in quantification of 5-HT4 receptors in serotonin
studies investigating memory and learning. The perfor-
mance of the constrained SIME was assessed by compar-
ing the results to those obtained using the original SIME
and the gold standard arterial blood sample-derived AIFs.
Methods
SIME
The SIME works on the assumption that the parent AIF
is common to all of the TACs and can be expressed using
a mathematical function. In its original implementation,
Feng et al. used an input function model [13] which is a
sum of a gamma variate function and two exponentials.
This function has six parameters and can be written as
Eq. 1.
CP(t) = (A1t−A2 − A3)e−λ1t+A2e−λ2t+A3e−λ3t (1)
The six parameters of the AIF function are estimated
together with the kinetic parameters by fitting the TACs
for multiple brain regions simultaneously. Therefore,
when a two-tissue compartment (2-TC) model with four
rate constants (K1–k4) is used to model m number of
regions of interest (ROIs), 4m+6 parameters are included
in the optimisation. The cost function can be written as
follows:
φ(p) =
m∑
i=1
n∑
j=1
wi,j
[
E¯i(tj) − Mi(tj)
]2 (2)
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where E¯i(tj) is the estimated model output, Mi(tj) is the
measured PET activity concentration at the jth time frame
of the ith region. Symbol m represents the number of
TACs to be fitted, n represents the number of time frames
for each TAC and wi,j are the weights applied to the model
and were set to 1 in our implementation to apply uniform
weighting. In order to account for the measured activity
in a PET scan, E¯i(tj) is computed by averaging Ei over the
length of the scanning interval:
E¯i(tj) = 1
tj
∫ t+j
t−j
Ei(s)ds (3)
Ei(t) = (1 − Vb)CP(t) ⊗ h[K1, k2, k3, k4]i +VbCWB(t)
(4)
where t−j = tj − tj/2, t+j = tj + tj/2 and tj is length
of frame j. CWB represents the whole blood TAC, CP is the
parent AIF, h is the impulse response of the 2-TC model
and Vb is the cerebral blood volume. As the original SIME
does not include any prior measurement of CWB, CP was
used to replace it in Eq. 4.
Constrained SIME
Some tracers can be converted into metabolite side prod-
ucts, causing an IDIF directly derived from PET images
to be incorrect as the contribution of radioactive metabo-
lites cannot be determined. The current standard method
to measure the concentration of metabolites includes the
collection of multiple arterial samples during the course of
the PET scan. The concentration of tracer at each sample
is measured to determine the whole blood curve. Next, the
concentration in blood plasma is measured and plasma to
whole blood ratios are plotted at each sample time point.
These samples are often fitted with a linear function to be
used as the plasma to whole blood ratio.
During a standard metabolite correction procedure, the
fraction of parent tracer to total activity in plasma, known
as the parent fraction, is determined from the plasma sam-
ples. This parent fraction is then fitted using a parametric
function, such as a bi-exponential function or the Hill
function, and the fitted curve is used to convert the plasma
curve to a metabolite-free AIF [14]. The Hill function can
be described as follows:
fHill(t) = 1 − (1 − a)t
b
c + tb (5)
Hence, the parent tracer concentration, CP, can be
expressed as a product of the whole blood curve, fitted
Hill function and plasma to whole blood ratio as shown in
Eq. 6.
CP(t) = CWB(t)fHill(t)Cratio(t) (6)
where Cratio is the ratio of tracer concentration in plasma
to whole blood as a function time and modelled using a
straight line equation: Cratio = d × t + e.
If CWB can be reliably measured from carotid arteries
in partial volume-corrected PET images, the relationship
shown in Eq. 6 can be used to model the AIF in the SIME
cost function. In this implementation, the input func-
tion part of the cost function contains only five unknown
parameters, three from the Hill function and two from the
linear function used to model the plasma to whole blood
ratio. The constrained SIMEmethod is illustrated in Fig. 1.
Data acquisition
All of the scans included in this study were performed at
Copenhagen University Hospital, Rigshospitalet, Copen-
hagen, Denmark. The study followed the ethical guide-
lines from the Helsinki declaration of 1975 (revised 1983)
and was approved by the Ethics Committee for Copen-
hagen and Frederiksberg ((KfF)01-274821). All subjects
gave written informed consent. The data were collected
as part of previous work published by Marner et al. [12]
and have been included in the current study from the
Cimbi Database [15] after approval from the Danish Data
Protection Agency (2015-331-1254).
Six healthy volunteers (three males and three females,
age range 21–44 years) were included in this study. Test
and retest scans were performed on the same day with
identical protocols. The PET data were acquired on an
18-ring GE Advance scanner (GE Healthcare, Milwaukee,
WI, USA). Each subject received an intravenous adminis-
tration of 11C-SC207145 with a mean activity of 572 MBq
(range 512–601 MBq), and high specific activity (mean
48.4 GBq/μmol, range of 34.2–71.0 GBq/μmol). Dynamic
PET acquisition was started before the tracer injection
and 3D PET data were acquired for 2 h. 3D-filtered back-
projection (6-mm Hann filter and 8.5-mm axial ramp
filter) was used in the image reconstruction and the PET
images were reconstructed on 128 × 128 × 35 volumes
with a voxel size of 2.0 mm × 2.0mm × 4.25mm. A trans-
mission source was used to derive maps for attenuation
correction [16]. PET data were corrected for randoms,
scatter and deadtime. Frames were binned using the fol-
lowing durations: 6 × 5 s, 10 × 15 s, 4 × 30 s, 5 × 2 min,
5 × 5 min and 5 × 10 min. As part of the PET study, arte-
rial blood samples were collected from the radial artery
at 46 time points with 5-s intervals in the early part of
the scan to get a good definition of the bolus shape.
Whole blood and plasma radioactivity were measured in
a well counter (COBRA 5003, Packard Instruments, Meri-
den, CT, USA). Additionally, six arterial samples were
withdrawn at times 3.5, 10, 17.5, 32.5, 55 and 85 mins
to measure the concentration of metabolites. The parent
fraction was measured using a column-switching HPLC
method [17] which was previously shown to provide a
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Fig. 1 Constrained SIME model used in the analysis. CP represents the AIF, CF represents the free state and CB of the 2-TC model. The CP was
modelled as a product of plasma to whole blood ratio and the Hill function. Three parameters of the Hill function (a, b, c) and two parameters of the
straight line function (d, e) were optimised simultaneously by fitting N (where N = 4) TACs extracted from different brain regions. CWB is derived from
PV-corrected PET images. TACs derived from the cerebellum, parietal cortex, hippocampus and striatum from one subject are shown on the right
reliable determination of radioactive products in plasma
for 11C-labelled radiopharmaceuticals [18]. The Hill func-
tion was fitted to the measured parent fraction and was
used to obtain the metabolite-free input function. The
arterial samples were corrected to account for the delay
between the radial artery and the brain by applying a nega-
tive time shift to match the first PET frame. No dispersion
correction was performed.
Subjects also had structural MRI scans on a 3T Siemens
Trio Scanner (Siemens Healthcare, Erlangen, Germany).
Three-dimensional volumetric T1-weighted MPRAGE
images (TR = 1380 ms, TI = 800 ms, TE = 2.6 ms and
flip angle = 9°) of the head were acquired in sagittal
planes for each subject. Images were reconstructed using
a 256 × 256 × 256 matrix with voxel dimensions of
1 × 1 × 1 mm.
Data analysis
An adapted version of an IDIF extraction method previ-
ously validated on 18F-FDG was used to derive the TAC
of the tracer in the whole blood [5]. As higher resolu-
tion time-of-flight (TOF) MR angiograms were not col-
lected as part of this study, MPRAGE images were used
in the carotid artery segmentation. One of the six sub-
jects had no visible arteries on the MPRAGE image and
was excluded from the analysis as a reliable carotid artery
segmentation was not feasible. For the rest of the sub-
jects, carotid arteries were segmented using ITK-SNAP
software application [19]. As part of the segmentation
procedure, MPRAGE images were thresholded to retain
the intensities greater than one third of the maximum
image intensity. This step was used to separate the carotid
arteries with higher signal from the background regions
and replaced the automatic tissue classification method
used in the originally published method. The tissue clas-
sification method did not yield the desired results for
these datasets possibly due to the presence of high T1 sig-
nal in the background regions close to the arteries. Once
the MPRAGE images were thresholded, a region-growing
algorithm with active contour evolution was applied to
delineate the arterial voxels [19].
The dynamic PET frames were registered to the
MPRAGE images using a six-parameter rigid registration.
The first 10 frames (90 s) of the dynamic PET data were
added together to obtain a summed image with a high
activity in the carotid arteries. This summed image was
then used in the image registration which was performed
using FSL Linear Image Registration Tool (FLIRT) [20].
The resulting transformation matrix was used to coalign
all of the PET frames to the MPRAGE image. PET frames
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were resampled to MR space using tri-linear interpola-
tion. The coregistered PET images were corrected for
partial volume (PV) effects using the single-target correc-
tion (STC)method [5] where the segmented carotid artery
mask was used as the only region of interest. An image-
derived PSF of 6.8-mm full width half maximum (FWHM)
was used in the PV correction. The mean intensity in the
segmented artery region of each PV-corrected PET frame
was calculated to derive the whole blood curve [5].
SIME requires TACs from multiple brain regions with
different kinetic behaviours to estimate the AIF. In our
implementation, TAC from the cerebellum was used to
reflect a low binding region, TACs from the parietal cortex
and hippocampus were used to reflect moderate binding
regions and TACs from the striatum was used as a high
binding region. Measured TACs from a single study are
illustrated in Fig. 1. Segmentation of these regions was
performed at Rigshospitalet, Copenhagen, Denmark [12].
The MPRAGE image of each subject was coregistered to
the PET data and was parcellated into 19 different regions
in the left and right hemispheres automatically using the
Pvelab software package [21]. The segmented ROI masks
were applied to the PET data to extract the desired TACs.
The SIMEmodel was implemented inMATLAB (Math-
Works, Inc., Natick, MA) using the COMKAT software
package [22] which contains software libraries to build
and solve compartmental models and perform parame-
ter estimations. SIME optimisation was performed using
the ordinary least squares method with uniform weight-
ing applied to all time frames [23]. An analytical Jacobian
of the AIF model was calculated to aid the optimisa-
tion. All four regions of interest were modelled using
a two-tissue compartment model. The value of cerebral
blood volume was not estimated and was assumed to
be 5% for all regions. The CWB was derived from PV-
corrected PET images. Only the first 90 min of dynamic
PET data were used in the analysis as this was pre-
viously shown to be acceptable for this tracer [12]. In
the original SIME method, the six parameters of Feng’s
AIF model [13] are estimated together with the kinetic
parameters.
In the constrained SIME method, three parameters of
the Hill function and two parameters of the plasma to
whole blood ratio were estimated by fitting the tissue
TACs simultaneously and the estimated parameters were
used with Eq. 3 to derive the parent AIF. This AIF was
then used to fit each TAC individually to obtain the kinetic
parameters K1, k2, k3 and k4. This second TAC fitting
step was applied to re-estimate the kinetic parameters of
each region of interest in a reduced parameter space per
region [8]. Total volume of distribution (VT) was com-
puted for each region using Eq. 7 and non-displaceable
binding potential (BPND) was calculated using Eq. 8, with
the cerebellum used as the reference region, VND.
VT = K1k2
(
1 + k3k4
)
(7)
BPND = VT − VNDVND (8)
The results of the constrained SIME and original SIME
were also compared to the gold standard method, where
the metabolite-corrected AIF derived from arterial sam-
ples was used to derive the kinetic parameters, VT
and BPND. Statistical comparisons were performed using
paired t tests. The results obtained from test and retest
studies were used to compare the reliability of VT esti-
mates obtained using the proposed method and arterial
samples. The intraclass correlation coefficient (ICC) was
computed using Eq. 9:
ICC = BMS − WMSBMS + WMS (9)
where BMS is the mean sum of squares between sub-
jects and WMS is the mean sum of squares between the
test and retest studies for each subject. This produces a
score between − 1 and + 1 which represents minimum
and maximum reliability respectively.
Results
Throughout this section, the original SIME with no prior
information is referred to as SIMEoriginal, the constrained
method with prior image-derived information is referred
to as SIMEconstrained and the AIF derived frommetabolite-
corrected arterial samples is referred to as AIFsamples.
The accuracy of the image-derived whole blood TAC
measurement was visually assessed against the blood
sample-derived whole blood curves. Examples of these
two curves are illustrated in Fig. 2 together with the
AIFsamples. A paired t test was used to compare the area
under curves (AUCs) of the measured and image-derived
whole blood curves. The peak and the tail parts of the
curves were assessed separately. No significant difference
was observed between the AUCs of the whole blood
curve tails (P = 0.10). However, a statistically significant
difference (P < 0.05) was present between the image-
derived and blood sample-derived whole blood peaks. A
good agreement was observed in 9 of 10 subjects, but in
one subject, the image-derived method yielded underes-
timated concentrations both in the peak and tail of the
whole blood curve. The reason for this is unknown but
may be caused by the errors propagated from segmenta-
tion and registration steps.
During SIMEconstrained optimisation, the parent frac-
tion is estimated together with kinetic parameters by
fitting the multiple tissue TACs simultaneously. Plots
of simultaneously fitted TACs for a representative sub-
ject is shown in Fig. 3. The model provided good fits
to the experimental data in all regions. Figure 4 illus-
trates the average of the estimated Hill functions using
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Fig. 2 Comparison of image-derived and arterial blood sample-derived whole blood curves for one subject plotted together with the
metabolite-free parent AIF derived from blood samples. The x-axis is set to log scale to display curve peaks and tails clearly
SIMEconstrained together with blood sample-derived par-
ent fractions averaged across 10 datasets. Error bars are
included to show variability in fitted parent fractions
at blood sample data points. A very good agreement
was observed between the blood sample-derived parent
fractions and SIMEconstrained estimated parent fractions.
Comparison of parent fraction values at metabolite sam-
ple time points did not show any significant difference
between SIMEconstrained and AIFsamples (P = 0.58). These
results indicate that SIMEconstrained was able to estimate
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Fig. 3 TACs from one subject with simultaneously fitted curves using
SIMEconstrained modelling
parent fractions with a comparable accuracy to blood
samples. Plasma to whole blood ratio values at these time
points were also compared and no significant difference
was seen between the plasma to whole blood ratio curves
estimated using SIMEconstrained and derived from arterial
samples (paired t test, P = 0.28).
AIFs estimated using the three methods are plotted in
Fig. 5. The AIF estimated using SIMEconstrained has a very
good agreement with the gold standard AIFsamples, partic-
ularly at the AIF peak whereas SIMEoriginal overestimated
the peak. AUCs of the peak and tails of the AIFs derived
using AIFsamples and SIMEconstrained were also compared
using a pairwise t test and no statistically significant
difference was observed (P = 0.50 and P = 0.52 respec-
tively). The estimated AIFs were used to fit TACs derived
from the cerebellum, parietal cortex, hippocampus and
striatum and estimated kinetic parameters were used to
calculate VT in each region. The averaged results for 10
datasets are plotted in Fig. 6 together with results obtained
using SIMEoriginal and AIFsamples. It can be seen that using
SIMEoriginal yielded VT estimates with 65% error for the
cerebellum, 47% for the parietal cortex, 36% for the hip-
pocampus and 50% for the striatum. Using SIMEconstrained
reduced the averaged percentage error to − 10% for the
cerebellum, − 10% for the parietal cortex, − 7% for the
hippocampus and− 11% for the striatum. Averaged across
all four regions, the absolute percentage error was reduced
by 40% on VT estimates and 16% in BPND estimates.
SIMEconstrained underestimated the VT in all of the four
regions whereas SIME produced overestimated VT values.
The estimated K1 values are illustrated in Fig. 7.
SIMEconstrained resulted in a significant improvement
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Fig. 4 Average of the parent fractions estimated using the SIMEconstrained plotted together with average of parent fractions derived from plasma
samples. Error bars represent the variation between estimated and measured parent fraction curves from 10 datasets
in K1 estimates compared to SIMEoriginal. When the
SIMEconstrained was used, the percentage error dropped to
4% for the cerebellum and hippocampus, 2% for the pari-
etal cortex and 3% for the striatum. Contrary to VT results,
SIMEconstrained produced slightly overestimated K1 val-
ues whereas SIMEoriginal significantly overestimated K1 in
all regions. The difference between K1 estimates between
SIMEconstrained and AIFsamples was not statistically signifi-
cant (P = 0.08).
Non-displaceable binding potential estimates in Table 1
show that SIMEconstrained was able to estimate this param-
eter with a reasonable accuracy whereas larger dis-
crepancies were observed when SIMEoriginal was used.
SIMEoriginal estimated BPND with 29.7, 30.3 and 8.6% error
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Fig. 5 AIFs derived using SIMEoriginal , SIMEconstrained and AIFsamples plotted together for one subject. The x-axis is set to log scale to display curve
peaks and tails clearly
Sari et al. EJNMMI Research  (2018) 8:58 Page 8 of 12
Cerebellum Parietal Ctx Hippocampus Striatum
0
10
20
30
40
50
60
70
V
T
 (
m
L/
cm
3 )
AIF
samples
SIME
original
SIME
constrained
Fig. 6 VT estimated for four brain regions using the AIFs estimated
from AIFsamples, SIMEoriginal and SIMEconstrained. The bars represent the
VT values estimated across 10 studies and error bars represent the
standard deviation
for the hippocampus, parietal cortex and striatum respec-
tively whereas these errors were reduced to 10.0, 9.0 and
1.4% respectively with SIMEconstrained. However, results
obtained using SIMEconstrained had a larger standard devi-
ation in BPND estimates by 7.0% on average compared to
the results obtained by arterial samples.
In Fig. 8a, VT estimations obtained using the proposed
method are plotted against the ones obtained using arte-
rial samples. While a good agreement was seen between
methods at lower VT values, a deviation was seen as
SIMEconstrained underestimated VT at higher values (i.e.
in the striatum). Paired t test analysis showed statisti-
cally significant difference between estimated VTs from
SIMEconstrained and AIFsamples (P < 0.05). Figure 8b shows
that there was a very good relationship between the BPND
between AIFsamples and SIMEconstrained. The linear fit to
BPND estimates from all brain regions and scans shows
that the SIMEconstrained was able to derivematching results
to the gold standard method, closely following the iden-
tity line. Paired t test showed no statistically significant
difference (P = 0.79) between BPND estimates using
SIMEconstrained and AIFsamples.
The intraclass correlation coefficient (ICC) results in
Fig. 9 illustrate reproducibility of all three methods by
comparing VT estimates obtained from test and retest
studies. AIFsamples yielded results with small test-retest
differences and high ICC, whereas SIMEoriginal produced
positive but much lower ICC results in all regions.
SIMEconstrained produced reproducible results between
test and retest scans, with ICC values of 0.74 for the
cerebellum, 0.84 for the parietal cortex, 0.83 for the hip-
pocampus and 0.52 for the striatum. These results indicate
that SIMEconstrained had only slightly lower reproducibility
than the AIFsamples.
Discussion
In this paper, our work to incorporate image-derived
whole blood concentration to improve the SIME anal-
ysis of dynamic PET data is presented. The proposed
method is compared against the original SIME with no
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Fig. 7 K1 estimated for four brain regions using the AIFs estimated from AIFsamples, SIMEoriginal and SIMEconstrained. The bars represent the K1 values
estimated across 10 studies and error bars represent the standard deviation
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Table 1 Average non-displaceable binding potential (BPND)
calculated across 10 scans with the standard deviation using
input function derived from AIFsamples, SIMEoriginal and
SIMEconstrained
AIFsamples SIMEoriginal SIMEconstrained
Cerebellum – – –
Parietal ctx. 0.42 ± 0.08 0.29 ± 0.26 0.46 ± 0.12
Hippocampus 0.90 ± 0.22 0.63 ± 0.60 0.98 ± 0.23
Striatum 3.55 ± 0.52 3.25 ± 0.96 3.50 ± 0.57
prior information and also against the gold standard arte-
rial sample-derived AIF. Anatomical MR images were
used with the STC method to correct for partial volume
effects and to obtain an accurate estimation of the whole
blood TAC from PET images. This whole blood curve was
included in the SIME cost function to reduce the number
of estimated parameters.
The constrained SIME was used to analyse dynamic
PET data from 11C-SB201745 serotonin receptor stud-
ies. Kinetic analysis of this tracer requires information
about concentration of metabolite products, which is tra-
ditionally extracted from multiple arterial samples. SIME
can be considered as a non-invasive alternative to analyse
such tracers but large errors were observed in the esti-
mated parameters when no prior information is included
to aid AIF estimation. Using information derived from
MRI-based PV-corrected PET images improved the K1
and more importantly the VT and BPND estimates which
are the main macroparameters sought in the analysis of
this tracer [12]. BPND estimates, based on the proposed
method and the gold standard arterial sample-derived
AIF, were not significantly different (P = 0.7). The intr-
aclass correlation results showed that the constrained
SIME method was able to provide a reproducible perfor-
mance in estimating VT between test and retest studies.
The original SIME showed a considerably poorer perfor-
mance with lower ICC scores.
The significant improvement in K1 estimates can be
explained by the direct link of this parameter to the early
part of the AIF. The original SIME method has difficulty
in accurately defining the AIF peaks but is more accurate
in estimating the tail [6] especially when blood sam-
ples are used to anchor the estimated AIF. This makes it
more successful in estimating macroparameters of kinetic
analysis (i.e. Ki, VT) rather than individual parameters.
Since a reliable measurement of the whole blood curve
is used in the constrained SIME, this method is supe-
rior in estimating the complete shape of the AIF curve,
including the peak. This should be valid for most tracers
except those with rapid uptake by red blood cells, which
would result in differences between the plasma and whole
blood curves.
The proposed method requires an accurate measure-
ment of the whole blood curve from PET images, plasma
to whole blood ratio and knowledge of an analytical func-
tion which can be used to define the parent fraction curve.
Various models are available in the literature to model the
parent fraction for different tracers [14]. In this work, the
Hill function was used as it was previously shown that it is
a suitable function to fit blood sample-derived parent frac-
tion curves in 11C-SB201745 studies [12]. A constrained
bi-exponential function, also with three parameters, is an
alternative function that can be used in the analysis of this
tracer, but this was not assessed in this paper. The plasma
to whole blood ratio was parameterised as a straight line
function where its parameters were optimised within the
cost function.
In this work, the input function estimated from the con-
strained SIME method was used to fit individual TACs
separately to estimate regional kinetic parameters. This
individual TAC fitting step can be beneficial in avoiding
local minima during the optimisation process, which is
a risk when high number of parameters are estimated to
fit multiple TACs at once. Furthermore, after estimating
the AIF, it is possible to perform voxelwise kinetic analy-
sis or fit some additional regions that were not included
in the SIME procedure. In this scenario, it is best to re-fit
the original SIME regions as well, so as to use the same
procedure for all ROIs.
One limitation of this study was the arterial blood sam-
pling protocol used to obtain the arterial input function.
AIF was sampled in 5–10-s intervals for the first 2 min,
which might affect the accuracy of the derived AIF peak.
As the blood samples are obtained from the radial artery,
which is distant to the brain, the measured AIFs can
suffer from delay and dispersion effects. There are avail-
able methods in the literature to correct for these effects
[24, 25] but errors can be present even after such cor-
rections. Therefore, it can be argued that SIME has the
potential to give more specific parameter estimates as it
directly measures the AIF using information from TACs
in the tissue of the interest.
The constrained SIME can be used to eliminate the
need for arterial sampling which is conventionally per-
formed in the analysis of PET tracers with radiometabolite
products in the blood plasma. The accuracy of the image-
derived whole blood curves depends on the performance
of carotid artery segmentation, PET-MR image registra-
tion and the partial volume correction of PET images. The
method used to obtain the image-derived whole blood
measurements was previously validated using 18F-FDG
datasets [5]. Results of the current study reconfirm that
the blood concentration could reliably be measured from
partial volume-corrected PET images. In order to use the
proposed method, the study needs to include anatomi-
cal MR images to be used in carotid artery segmentation.
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Fig. 8 a VT and b BPND estimated using SIMEconstrained compared to VT and BPND determined by AIF from arterial samples. Results from each scan
are shown per each ROI. A linear function was fitted to the data points and plotted together with the line of identity
TOF-MR angiography is capable of providing higher res-
olution images with a better contrast in the arteries and
therefore more straightforward artery segmentation than
the T1-weighted MPRAGE images used in this study.
In this study, proof of principle of using a constrained
SIME method to non-invasively analyse PET tracers
with radiometabolites was demonstrated. The proposed
method may be applicable to other PET tracers provided
that an accurate determination of the whole blood curve
can be obtained and multiple time activity curves with
different kinetic behaviours are included in the field of
view.
Conclusions
In this paper, we present a method which can be used to
non-invasively analyse dynamic PET data in the presence
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Fig. 9 Intraclass correlation coefficient (ICC) scores of the VT estimates obtained using AIFsamples, SIMEoriginal and SIMEconstrained. + 1 represents
maximum reliability whereas − 1 represents minimum reliability
of radiometabolite side products in the plasma. The proof
of principle was demonstrated with 11C-SB201745 data.
This method is intended as a general procedure although
further evaluation is required for application to other
tracers.
Anatomical MR images were utilised with the STC
partial volume correction technique to derive reliable
estimates of the whole blood TACs from coregistered PET
images. The parent fraction of the tracer in the plasma and
plasma to whole blood concentration relationship were
modelled using parametric equations whose parameters
were estimated within the SIME optimisation. The pro-
posedmethod was able to derive K1 andmacroparameters
VT and BPND with good accuracy and precision.
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